Clinical Report: Evaluation of Factors Influencing Embryo Quality in Endometriosis

Overview

This study identifies key clinical factors that impact embryo quality and quantity in endometriosis patients undergoing IVF/ICSI-ET. The findings suggest that specific ovarian reserve indicators can effectively predict oocyte yield and improve treatment strategies.

Background

Endometriosis is a significant cause of infertility, affecting approximately 30% of affected women. The condition is associated with impaired oocyte quality and reduced embryonic development potential, complicating fertility treatments like IVF/ICSI-ET. Understanding the factors influencing embryo quality is crucial for optimizing treatment outcomes in this patient population.

Data Highlights

Key Findings

• Anti-Müllerian Hormone (AMH) levels and Antral Follicle Count (AFC) are strong predictors of oocyte yield in endometriosis patients.
• The presence of bilateral endometriomas negatively impacts both oocyte yield and high-quality embryo rates.
• GnRH agonist pre-treatment improves clinical outcomes in IVF/ICSI cycles for endometriosis patients.
• The predictive nomogram developed can assist in early prognostication of ovarian response.
• Endometriosis patients may require higher gonadotropin doses and produce fewer viable embryos compared to those without the condition.

Clinical Implications

Clinicians should consider AMH and AFC when assessing endometriosis patients for IVF/ICSI-ET to tailor treatment strategies effectively. The use of GnRH agonists may enhance embryo quality and quantity, warranting further exploration in clinical practice.

Conclusion

The study underscores the importance of specific clinical factors in predicting embryo quality and quantity in endometriosis patients. Utilizing these predictors can lead to more personalized and effective fertility treatment approaches.

Related Resources & Content

1. Author(s)/Org, Source, Year -- Title
2. Author(s)/Org, Source, Year -- Title
3. Author(s)/Org, Source, Year -- Title
4. Author(s)/Org, Source, Year -- Title
5. ESHRE guideline: ovarian stimulation for IVF/ICSI: an update in 2025, Human Reproduction, 2025
6. Endometriosis as a risk factor: impact on IVF outcomes and reproductive parameters: a systematic review and meta-analysis, PubMed
7. Study Details | NCT06375811 | Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp, ClinicalTrials.gov
8. ESHRE guideline: ovarian stimulation for IVF/ICSI: an update in 2025‡ | Human Reproduction | Oxford Academic
9. Endometriosis as a risk factor: impact on IVF outcomes and reproductive parameters: a systematic review and meta-analysis - PubMed
10. Study Details | NCT06375811 | Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp | ClinicalTrials.gov